BOSTON, June 23, 2021 – Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, has named global healthcare marketing and sales leader Sheeza Khawar Hussain as its first-ever chief commercial officer (CCO). Her appointment comes at a pivotal time in Biofourmis’ growth trajectory, as the company continues to expand the number of health systems leveraging its AI-based care-at-home technology, including solutions for Hospital at Home, post-acute care and chronic condition management.
Most recently, Ms. Hussain was a member of the senior leadership team at Hillrom, a $2.9-billion global medical technology leader, serving as vice president of the Connected Care Solutions division. She also managed Hillrom’s North Carolina location with 300 employees while guiding more than 50 sales executives.
Ms. Hussain holds degrees in computer engineering and business management. After working as an engineer at IBM and Nortel, she shifted to marketing. At Hillrom, where she spent almost 12 years, she led marketing communications, commercial marketing, product management and business partnership teams and functions. Most recently, she held two vice president positions, first leading Hillrom’s global Safe Patient Handling business and second as the national sales leader for the Connected Care Solutions business.
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
“As more and more health system leaders recognize the need for care-at-home programs, Sheeza and her team will ensure that they turn first to Biofourmis’ Biovitals® solutions—including our turnkey Hospital@Home platform that we developed with Brigham that has demonstrated real-world results in clinically validated studies,” said Kuldeep Singh Rajput, CEO and co-founder of Biofourmis. “Sheeza will be leading the charge to tell the story of how our care-at-home solutions reduce costs by 38%, lower readmissions by 70%, and increase physical activity by 32%” [from data published in Annals of Internal Medicine].
Ms. Hussain says the timing couldn’t be better given the market’s recognition that the future of healthcare will increasingly include the home. “Biofourmis offers market-leading innovations that help clinicians deliver next-level virtual care, and we provide them with the flexibility to ensure that the right care will be delivered to the right patient at the right time in the right place,” she said. “We’re experiencing a shift from solving existing healthcare problems to predicting them before they happen, and Biofourmis’ technology is leading this change.”